Abstract
The hepatitis C virus (HCV) is the most common blood-borne infection and affects approximately 2% of the U.S. population, with higher rates occurring in some segments of the population. Chronic pain affects approximately 35% of the general population, with 15% of individuals experiencing daily pain. In contrast, the prevalence of chronic pain among HCV patients may exceed 65%. The reasons for the high rates of chronic pain among HCV patients are not clear. More than two-thirds of HCV patients have a history of substance use disorder (SUD), and history of SUD is associated with the development of pain. HCV patients also have high rates of co-morbid psychiatric disorders, which are also associated with chronic pain. The purpose of this presentation will be to outline the issue of chronic pain and substance use among HCV patients and to describe factors that may lead to the high rate of chronic pain in this patient population. The results of ongoing studies that examined the role of biopsychosocial factors in the development and exacerbation of chronic pain in HCV patients will also be described.
Highlights
The hepatitis C virus (HCV) is the most common blood-borne infection and affects approximately 2% of the U.S population, with higher rates occurring in some segments of the population
More than two-thirds of HCV patients have a history of substance use disorder (SUD), and history of SUD is associated with the development of pain
HCV patients have high rates of co-morbid psychiatric disorders, which are associated with chronic pain
Summary
The hepatitis C virus (HCV) is the most common blood-borne infection and affects approximately 2% of the U.S population, with higher rates occurring in some segments of the population. Chronic pain and substance use in patients with Hepatitis C From 1st International Congress on Neurobiology and Clinical Psychopharmacology and European Psychiatric Association Conference on Treatment Guidance Thessaloniki, Greece.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
